Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats

Cell Transplantation

Volumn 11, Issue 1, 2002, Pages 5-16

  Veng, L M ^a   Bjugstad, K B ^a   Freed, C R ^a   Marrack, P ^b   Clarkson, E D ^a   Bell, K P ^a   Hutt, C ^a   Zawada, W M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Dopamine; Immunosuppression; Major histocompatability complex (MHC); Neural transplantation; Parkinson's disease; Xenotransplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHAMPHETAMINE; OXIDOPAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DONOR; DOPAMINERGIC NERVE CELL; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; HOST CELL; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MESENCEPHALON; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TREATMENT OUTCOME; XENOGRAFT;

ANIMALIA;

EID: 0036131316     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096020198389735     Document Type: Article

References (60)

1. Estimation of nuclear population from microtome sections
2. Cell-mediated xenoresponses: Strong or weak?
3. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
4. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease
5. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants
6. Cross-species neural grafting in a rat model of Parkinson's disease
7. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons
8. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
9. Studies of transplantation immunology with major histocompatibility complex knockout mice
10. Cloned transgenic calves produced from nonquiescent fetal fibroblasts
11. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultra-structural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry
12. Improved renal function in mouse kidney allografts lacking MHC class I antigens
13. Bovine chromaffin cells for CNS transplantation do not elicit xenogeneic T cell proliferative responses in vitro
14. The influence of xenotransplant immunogenicity and immunosuppression on host MHC expression in the rat CNS
15. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
16. Xenotransplantation of transgenic fetal pig dopamine neurons to rats and systemic prevention of host complement-mediated cell lysis
17. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from rat to MHC class II deficient mice
18. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from rat to MHC-deficient mice to adult rats
19. Prevention of xenograft rejection by masking donor HLA class I antigens
20. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results
21. Immunocytochemical characterization of the cellular immune response to intracerebral xenografts of brain tissue
22. Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: Effects of cyclosporin A treatment
23. Microglial MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus
24. Immune reactions against intracerebral murine xenografts of fetal hippocampal tissue and cultured cortical astrocytes in the adult rat
25. Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study
26. Transplantation of human fetal dopamine cells for Parkinson's disease
27. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
28. Embryonic dopamine cell transplantation for severe Parkinson's disease
29. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons
30. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology
31. Direct and indirect recognition: The role of MHC antigens in graft rejection
32. Mice lacking major histocompatibility complex class I and class II molecules
33. Immunosuppression for neural xenografts: A comparison of cyclosporin and anti-CD25 monoclonal antibody
34. Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease
35. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
36. Cell transplantation for central nervous system disorders
37. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: Immune responses and functional effects
38. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
39. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
40. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts
41. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents
42. Production of genetargeted sheep by nuclear transfer from cultured somatic cells
43. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: Tolerance induction by anti-T-cell antibodies
44. Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS
45. Prevention of mouse-rat brain xenograft rejection by a combination therapy of cyclosporin A, prednisolone and azathioprine
46. Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats
47. Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamsterto-rat cardiac xenograft
48. The role of T-cell costimulatory activation pathways in transplant rejection
49. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts
50. Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation
51. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self
52. The immune response to intracerebral neural grafts
53. Leucocyte recruitment and inflammation in the CNS
54. Intracerebral xenografts of human mesencephalic tissue into athymic rats: Immunochemical and in vivo electrochemical studies
55. Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats
56. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: Evidence for functional reinnervation
57. Function of intraventricular human mesencephalic xenografts in immunosuppressed rats: An electrophysiological and neurochemical analysis
58. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system
59. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies
60. Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats